M. Garrido-Cumbrera
H. Marzo-Ortega
L. Christen
L. Carmona
J. Correa-Fernndez
S. Sanz-Gomez
E. Mateus
S. Makri
P. Plazuelo-Ramos
L. Grange
S. Mingolla
K. Antonopoulou
D. Webb
C. Jacklin
S. Irwin
V. Navarro-Compn
Universidad de Sevilla, Health & Territory Research (HTR), Seville, Spain
University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
Leeds Teaching Hospitals NHS Trust, Leeds Biomedical Research Centre, Leeds, United Kingdom
Novartis Pharma AG, Patient Engagement, Basel, Spain
Institute for Musculoskeletal Health, Madrid, Spain
Liga Portuguesa Contra as Doenças Reumáticas (LPCDR), Management, Lisbon, Portugal
NOVA Medical School—Comprehensive Health Research Center (CHRC), Lisbon, Portugal
Cyprus League Against Rheumatism (CYPLAR), Management, Nicosia, Cyprus
Spanish Federation of Spondyloarthritis Associations (CEADE), Presidency, Madrid, Spain
French League Against Rheumatism (AFLAR), Management, Grenoble, France
Centre Hospitalier Universitaire de Grenoble, Grenoble, France
Italian National Association of People with Rheumatic and Rare Diseases (APMARR), Communication, Bari, Italy
Hellenic League Againts Rheumatism (ELEANA), Management, Athens, Greece
National Rheumatoid Arthritis Society (NRAS), Management Department, London, United Kingdom
National Rheumatoid Arthritis Society (NRAS), Management Department, London, United Kingdom
Arthritis Action, Management, London, United Kingdom
Hospital Universitario La Paz, Madrid, Spain
Spain
United Kingdom
Switzerland
Portugal
Cyprus
France
Italy
Greece
N/A
Infectious Diseases (ID)
Coronavirus disease
N/A
N/A
N/A
Multinational
Cross-Sectional
I
N/A
Janssen and Novartis
N/A